ProQR Therapeutics N.V Live Stock Price Today, Share Analysis and Chart

Name: ProQR Therapeutics N.V: Is Infosys Ltd. worth buying?
Item: ProQR Therapeutics N.V
Rating: 1.57966675
Author: Trendlyne DVM scores

about

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The onl...

2.19 -0.05 (-2.23%)

52.60% Fall from 52W High

184.4K

XNAS Volume

XNAS 29 Jul, 2025 4:00 PM (EDT)

Board Meeting

The next board meeting for ProQR Therapeutics N.V is on 08 Aug 2025 for the purpose of ProQR Therapeutics NV Second Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

14.7 / 100

Technically Neutral

48.5 / 100

1Yr Price target upside is 305%

8 analysts

ProQR Therapeutics N.V Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..